Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Subscribe To Our Newsletter & Stay Updated
